Cabaletta Bio

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.

About CABA

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.

CEO

Steven Nichtberger

CEOSteven Nichtberger

Employees

Employees54

Headquarters

Philadelphia, Pennsylvania

HeadquartersPhiladelphia, Pennsylvania

Founded

2017

Founded2017

Employees

Employees54

CABA Key Statistics

Market cap

16.04M

Market cap16.04M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

822.52K

Average volume822.52K

High today

$0.6671

High today$0.6671

Low today

$0.6147

Low today$0.6147

Open price

$0.644

Open price$0.644

Volume

410.96K

Volume410.96K

52 Week high

$14.95

52 Week high$14.95

52 Week low

$0.59

52 Week low$0.59

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

CABA Earnings

-$0.60

-$0.40

-$0.20

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Oct 31, Pre-Market

ActualExpected Oct 31, Pre-Market